Literature DB >> 23518318

The translocator protein (TSPO): a novel target for cancer chemotherapy.

Christopher J D Austin1, Jan Kahlert, Michael Kassiou, Louis M Rendina.   

Abstract

The translocator protein (TSPO) is an 18 kDa transmembrane protein primarily found in the outer mitochondrial membrane where it forms a key part of the mitochondrial permeability transition pore (MPTP). Omnipresent in almost all tissues, TSPO up-regulation has been connected to neuronal damage and inflammation, making the protein an important bio-imaging marker for disease progression. More recently, TSPO has attracted attention as a possible molecular target for tumour imaging and chemotherapy. In this review we summarize TSPO's molecular characteristics and highlight research progress in recent years in the field of TSPO-targeted cancer diagnostics and treatments. Crown
Copyright © 2013. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23518318     DOI: 10.1016/j.biocel.2013.03.004

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  32 in total

1.  4'-Chlorodiazepam Protects Mitochondria in T98G Astrocyte Cell Line from Glucose Deprivation.

Authors:  Eliana Baez; Gina Paola Guio-Vega; Valentina Echeverria; Daniel Andres Sandoval-Rueda; George E Barreto
Journal:  Neurotox Res       Date:  2017-04-13       Impact factor: 3.911

Review 2.  Translocator protein (18 kDa): an update on its function in steroidogenesis.

Authors:  V Papadopoulos; J Fan; B Zirkin
Journal:  J Neuroendocrinol       Date:  2018-02       Impact factor: 3.627

Review 3.  Translocator protein-mediated pharmacology of cholesterol transport and steroidogenesis.

Authors:  Vassilios Papadopoulos; Yasaman Aghazadeh; Jinjiang Fan; Enrico Campioli; Barry Zirkin; Andrew Midzak
Journal:  Mol Cell Endocrinol       Date:  2015-03-25       Impact factor: 4.102

4.  Multilayer photodynamic therapy for highly effective and safe cancer treatment.

Authors:  Ling Yang; Shaojuan Zhang; Xiaoxi Ling; Pin Shao; Ningyang Jia; Mingfeng Bai
Journal:  Acta Biomater       Date:  2017-03-09       Impact factor: 8.947

5.  Mitochondrial Translocator Protein (TSPO) Function Is Not Essential for Heme Biosynthesis.

Authors:  Amy H Zhao; Lan N Tu; Chinatsu Mukai; Madhu P Sirivelu; Viju V Pillai; Kanako Morohaku; Roy Cohen; Vimal Selvaraj
Journal:  J Biol Chem       Date:  2015-12-01       Impact factor: 5.157

Review 6.  The changing landscape in translocator protein (TSPO) function.

Authors:  Vimal Selvaraj; Douglas M Stocco
Journal:  Trends Endocrinol Metab       Date:  2015-03-21       Impact factor: 12.015

Review 7.  Mitochondrial function and regulation of macrophage sterol metabolism and inflammatory responses.

Authors:  Annette Graham; Anne-Marie Allen
Journal:  World J Cardiol       Date:  2015-05-26

8.  The role of PBR/TSPO in steroid biosynthesis challenged.

Authors:  Douglas M Stocco
Journal:  Endocrinology       Date:  2014-01       Impact factor: 4.736

9.  A corrole nanobiologic elicits tissue-activated MRI contrast enhancement and tumor-targeted toxicity.

Authors:  Jessica D Sims; Jae Youn Hwang; Shawn Wagner; Felix Alonso-Valenteen; Chris Hanson; Jan Michael Taguiam; Richard Polo; Ira Harutyunyan; Gevorg Karapetyan; Karn Sorasaenee; Ahmed Ibrahim; Eduardo Marban; Rex Moats; Harry B Gray; Zeev Gross; Lali K Medina-Kauwe
Journal:  J Control Release       Date:  2015-08-31       Impact factor: 9.776

Review 10.  Nanotechnology inspired tools for mitochondrial dysfunction related diseases.

Authors:  Ru Wen; Bhabatosh Banik; Rakesh K Pathak; Anil Kumar; Nagesh Kolishetti; Shanta Dhar
Journal:  Adv Drug Deliv Rev       Date:  2016-01-09       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.